BMY BRISTOL-MYERS SQUIBB CO
2026Q2 · CUSIP 110122108 · Sector: Healthcare & Biotech
Funds are exiting, but the price is holding
2,536 funds held BMY at the end of 2026Q2, down 9 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $49.2B(YoY +3.1%), the P/E is 13.5x, return on equity is 41.6%. BMY has had 28 buying rushes in its history, and the price moved +0.2% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.
How many funds owned it, quarter by quarter
Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.
What happened after each past buying rush 28 times in its history
| Quarter of the rush | How unusual then | Price, next 3 months | Price, next 6 months |
|---|---|---|---|
| 2026Q1 | Top 5% | +16.6% | — |
| 2025Q4 | Top 5% | -1.9% | +10.9% |
| 2024Q4 | Top 1% in the market | -12.3% | -8.4% |
| 2024Q3 | Top 1% in the market | -0.6% | -15.4% |
| 2022Q4 | Top 5% | -6.5% | -10.9% |
| 2022Q2 | Top 10% | +3.1% | -3.5% |
| 2022Q1 | Top 1% in the market | -3.1% | +0.3% |
| 2021Q4 | Top 5% | +14.8% | +11.3% |
These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.
Show all the numbers (large funds, value held, options…) ▾ Collapse ▴
These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.
Fundamentals
Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable
P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden
FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden
As of 2026-06-30 · SEC filings (XBRL)
Email me the next update
2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.